Todd L. Wandstrat
Technik-/Wissenschafts-/F&E-Leiter bei TREVENA, INC.
Ursprung des Netzwerks ersten Grades von Todd L. Wandstrat
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 18 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Todd L. Wandstrat
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Director of Finance/CFO President | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Sales & Marketing | |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Operating Officer | |
CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer | |
IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Brighton Biotech, Inc.
Brighton Biotech, Inc. BiotechnologyHealth Technology Brighton Biotech, Inc. provides medical research services. It specializes in acquiring and developing pharmaceutical and biotechnology products intended for the treatment and prevention of serious unmet medical needs. The company was founded in 2010 and is headquartered in New York, NY. | Biotechnology | Corporate Officer/Principal | |
ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree | |
The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
St. Joseph's University | College/University | Masters Business Admin | |
University of Toronto | College/University | Doctorate Degree Graduate Degree | |
Robert Wood Johnson Medical School | College/University | Doctorate Degree | |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Director/Board Member | |
The Nathaniel Adamczyk Foundation | Director/Board Member | ||
LANTHEUS HOLDINGS, INC. | Medical Specialties | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Stanford Law School | College/University | Graduate Degree Graduate Degree | |
Pennsylvania Biotechnology Center of Bucks County | Director/Board Member | ||
UNC School of Medicine | College/University | Corporate Officer/Principal | |
EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
American College of Neuropsychopharmacology
American College of Neuropsychopharmacology Miscellaneous Commercial ServicesCommercial Services The American College of Neuropsychopharmacology provides a range of resources related to psychopharmacology and related fields. The non-profit company is based in Brentwood, TN. The company's Neuropsychopharmacology Reviews publication offers authoritative and timely coverage of contemporary topics in the field. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
New Xellia Group A/S
New Xellia Group A/S Financial ConglomeratesFinance New Xellia Group A/S operates as an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
Pamlico BioPharma, Inc.
Pamlico BioPharma, Inc. BiotechnologyHealth Technology Pamlico BioPharma, Inc. provides antibody therapeutics services. It develops fully-human monoclonal antibody (hmAb) therapeutics for the rapid diagnosis and treatment of infectious diseases and cancer. The firms lead program is focused on severe pneumonia caused by streptococcus pneumoniae (SPN), and is in preclinical IND-directed activities for a mAb cocktail and a companion point-of-care (POC) diagnostic against three serotypes that account for over 40% of SPN infections. The company was founded on 18 December, 2014 and is headquartered in Oklahoma, OK. | Biotechnology | Director/Board Member | |
NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TamuroBio, Inc.
TamuroBio, Inc. Miscellaneous Commercial ServicesCommercial Services Tamurobio, Inc. provides biotechnology services. The company was founded in 2019 and is headquartered in Wayne, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Exacis Biotherapeutics, Inc.
Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Medical/Nursing Services | Chairman | |
ACERAGEN, INC. | Biotechnology | Chairman Director/Board Member |
Statistik
International
Vereinigte Staaten | 45 |
Kanada | 3 |
Vereinigtes Königreich | 2 |
Norwegen | 2 |
Dänemark | 2 |
Sektoral
Health Technology | 32 |
Consumer Services | 9 |
Commercial Services | 7 |
Distribution Services | 2 |
Finance | 2 |
Operativ
Director/Board Member | 141 |
Independent Dir/Board Member | 61 |
Corporate Officer/Principal | 50 |
Chief Executive Officer | 19 |
Chairman | 18 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Lonnie Moulder | 31 |
Mark Corrigan | 29 |
Scott Braunstein | 26 |
Julie McHugh | 26 |
Jake Nunn | 23 |
Maxine Gowen | 23 |
Michael Dougherty | 18 |
Anne Phillips | 14 |
Barbara Yanni | 13 |
Scott Applebaum | 11 |
Mark Demitrack | 8 |
Carrie Bourdow | 6 |
Marvin Johnson | 5 |
Barry Shin | 5 |
Angela Bagley | 5 |
- Börse
- Insiders
- Todd L. Wandstrat
- Unternehmensverbindungen